Brii Biosciences Statistics

Total Valuation

HKG:2137 has a market cap or net worth of HKD 1.50 billion. The enterprise value is -990.46 million.

Market Cap	1.50B
Enterprise Value	-990.46M

Important Dates

The next estimated earnings date is Monday, May 19, 2025.

Earnings Date	May 19, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2137 has 719.18 million shares outstanding. The number of shares has increased by 0.30% in one year.

Current Share Class	n/a
Shares Outstanding	719.18M
Shares Change (YoY)	+0.30%
Shares Change (QoQ)	+0.15%
Owned by Insiders (%)	4.94%
Owned by Institutions (%)	1.03%
Float	521.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	25.68
PB Ratio	0.54
P/TBV Ratio	0.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	1.83
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	2.47

Financial Position

The company has a current ratio of 31.18, with a Debt / Equity ratio of 0.01.

Current Ratio	31.18
Quick Ratio	29.97
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-168.55

Financial Efficiency

Return on equity (ROE) is -18.05% and return on invested capital (ROIC) is -8.73%.

Return on Equity (ROE)	-18.05%
Return on Assets (ROA)	-8.44%
Return on Invested Capital (ROIC)	-8.73%
Return on Capital Employed (ROCE)	-15.17%
Revenue Per Employee	597,142
Profits Per Employee	-5.52M
Employee Count	98
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +67.20% in the last 52 weeks. The beta is 1.53, so HKG:2137's price volatility has been higher than the market average.

Beta (5Y)	1.53
52-Week Price Change	+67.20%
50-Day Moving Average	2.09
200-Day Moving Average	1.31
Relative Strength Index (RSI)	56.01
Average Volume (20 Days)	5,058,925

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2137 had revenue of HKD 58.52 million and -540.77 million in losses. Loss per share was -0.74.

Revenue	58.52M
Gross Profit	58.52M
Operating Income	-424.39M
Pretax Income	-545.26M
Net Income	-540.77M
EBITDA	-422.00M
EBIT	-424.39M
Loss Per Share	-0.74

Full Income Statement

Balance Sheet

The company has 2.47 billion in cash and 29.82 million in debt, giving a net cash position of 2.44 billion or 3.39 per share.

Cash & Cash Equivalents	2.47B
Total Debt	29.82M
Net Cash	2.44B
Net Cash Per Share	3.39
Equity (Book Value)	2.77B
Book Value Per Share	3.87
Working Capital	2.49B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -396.82 million and capital expenditures -3.44 million, giving a free cash flow of -400.25 million.

Operating Cash Flow	-396.82M
Capital Expenditures	-3.44M
Free Cash Flow	-400.25M
FCF Per Share	-0.56

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-725.21%
Pretax Margin	-931.75%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

HKG:2137 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.30%
Shareholder Yield	-0.30%
Earnings Yield	-35.98%
FCF Yield	-26.63%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2137 has an Altman Z-Score of 1.65. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.65
Piotroski F-Score	n/a